Strategic Biobank BIOMEX is Europe’s leading supplier of human biospecimens with in-house donor centers in Heidelberg, Munich, and Cameroon, offering a robust supply chain for diagnostics and life sciences. Sales opportunities exist in expanding external storage, study site services, and complete external studies to accelerate customers' time to market.

IVDR Expertise The company supports development, validation, registration, and manufacturing of in vitro diagnostics under current IVDR regulations. This positions BIOMEX as a compliance-savvy partner for biotech firms seeking regulated biospecimen processing, increasing potential for long-term collaborations in regulated markets.

Broad Service Suite Beyond biospecimens, BIOMEX offers biospecimen processing, cell-based assays, sequencing services, and cell isolation. Cross-selling opportunities exist with pharma and R&D teams needing end-to-end workflows from sample sourcing to data generation.

Global Outreach Active participation in international events (CACLP, EMBO|EMBL, ASGCT) and a growing network of laboratories, study sites, and medical experts indicate readiness to engage multinational pharmaceutical and biotech customers and expand geographic reach, especially in Asia and Europe.

Growth Signals Revenue range indicates substantial scale and customer demand. The recent expansion into new symposiums and the addition of gene and cell therapy-focused presence (ASGCT) suggest BIOMEX is evolving with market trends toward advanced therapies, providing a foothold for selling high-value biospecimen and assay services.